Stocks and Investing Stocks and Investing
Thu, July 28, 2022

Michael Wiederhorn Maintained (TDOC) at Buy with Decreased Target to $55 on, Jul 28th, 2022


Published on 2024-10-27 22:16:20 - WOPRAI, Michael Wiederhorn
  Print publication without navigation


Michael Wiederhorn of Oppenheimer, Maintained "Teladoc Health, Inc." (TDOC) at Buy with Decreased Target from $65 to $55 on, Jul 28th, 2022.

Michael has made no other calls on TDOC in the last 4 months.



There are 11 other peers that have a rating on TDOC. Out of the 11 peers that are also analyzing TDOC, 9 agree with Michael's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • David Grossman of "Stifel" Maintained at Hold with Decreased Target to $36 on, Wednesday, June 29th, 2022
  • John Eade of "Argus Research" Downgraded from Strong Buy to Hold on, Thursday, May 5th, 2022
  • Jonathan Yong of "Credit Suisse" Downgraded from Buy to Hold and Decreased Target to $35 on, Thursday, April 28th, 2022
  • Matt Hewitt of "Craig-Hallum" Maintained at Hold with Decreased Target to $30 on, Thursday, April 28th, 2022
  • Ryan Daniels of "William Blair" Downgraded from Buy to Hold on, Thursday, April 28th, 2022
  • Sandy Draper of "Guggenheim" Downgraded from Strong Buy to Hold on, Thursday, April 28th, 2022
  • Stan Berenshteyn of "Wells Fargo" Downgraded from Buy to Hold and Held Target at $40 on, Thursday, April 28th, 2022
  • George Hill of "Deutsche Bank" Maintained at Hold with Decreased Target to $44 on, Thursday, April 28th, 2022
  • Daniel Grosslight of "Citigroup" Downgraded from Strong Buy to Hold and Decreased Target to $43 on, Thursday, April 28th, 2022


These are the ratings of the 2 analyists that currently disagree with Michael


  • Richard Close of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $50 on, Thursday, April 28th, 2022
  • Sean Dodge of "RBC Capital" Maintained at Buy with Decreased Target to $65 on, Thursday, April 28th, 2022

Contributing Sources